Previous Article | Next Article ![]()
Infection and Immunity, July 2001, p. 4521-4527, Vol. 69, No. 7
Division of Pulmonary and Critical Care
Medicine,1 Department of
Pediatrics,2 Belfer Gene Therapy Core
Facility,3 and Institute of Genetic
Medicine,4 Weill Medical College of Cornell
University, New York, New York
Received 8 December 2000/Returned for modification 9 February
2001/Accepted 9 April 2001
To develop a Pseudomonas aeruginosa vaccine
that allows the host immune system to select the antigens, we
hypothesized that dendritic cells (DC) pulsed with P.
aeruginosa would induce protective immunity against pulmonary
infections with P. aeruginosa. Incubation of murine bone
marrow-derived DC with P. aeruginosa in vitro led to
uptake of P. aeruginosa and activation of the DC.
Spleen-derived CD4+ cells from mice immunized with
P. aeruginosa-pulsed DC showed increased proliferation,
demonstrating that DC pulsed with P. aeruginosa were
capable of eliciting a P. aeruginosa-specific immune
response. To evaluate if P. aeruginosa-pulsed DC can
induce protective immunity against P. aeruginosa
pulmonary infection, DC incubated with P. aeruginosa in
vitro were administered systemically to syngeneic mice, and the mice
were then challenged by intrapulmonary infection with P.
aeruginosa (5 × 104 CFU/mouse) 13 days later.
Unimmunized control mice and mice who had previously received naive DC
or DC stimulated with lipopolysaccharide or Escherichia
coli died within 72 h. In contrast, 45% of mice receiving
P. aeruginosa-pulsed DC demonstrated prolonged survival (>14 days). Finally, DC-pulsed with heat-inactivated P.
aeruginosa protected CD8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4521-4527.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Protection against Pulmonary Infection with Pseudomonas
aeruginosa following Immunization with P.
aeruginosa-Pulsed Dendritic Cells
/
but not
CD4
/
mice, demonstrating that CD4+ T cells
were required for the DC pulsed with P. aeruginosa to induce protective immunity.
*
Corresponding author. Mailing address: Weill Medical
College of Cornell University, New York Presbyterian Hospital, 520 East 70th St., ST 505, New York, NY 10021. Phone: (212) 746-2258. Fax: (212)
746-8383. E-mail: geneticmedicine{at}med.cornell.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»